Pierre Chauvelot1,2,3, Tristan Ferry1,2,3, Virginie Tafani3, Alan Diot3, Jason Tasse3,4, Anne Conrad1,2,3, Christian Chidiac1,2,3, Evelyne Braun1,2, Sébastien Lustig2,5, Frédéric Laurent2,3,6, Florent Valour1,2,3. 1. Departement of Infectious Diseases, Hospices Civils de Lyon, Lyon, France. 2. French Regional Reference Center for Complex Bone and Joint Infection (CRIOAc), Hospices Civils de Lyon, Lyon, France. 3. International Centre for Research in Infectiology, INSERM U1111, Claude Bernard Lyon 1 University, Lyon, France. 4. BioFilm Control, Saint-Beauzire, France. 5. Orthopedic Surgery Unit, Hospices Civils de Lyon, Lyon, France. 6. Laboratory of bacteriology, French National Reference Centre for Staphylococci, Hospices Civils de Lyon, Lyon, France.
Abstract
Introduction: Corynebacteria represent often-neglected etiological agents of post-traumatic and/or post-operative bone and joint infection (BJI). We describe here clinical characteristics and bacteriological determinants of this condition. Methods: A retrospective cohort study described characteristics, outcome and determinants of treatment failure of all patients with proven Corynebacterium spp. BJI (i.e., ≥2 culture-positive gold-standard samples). Available strains were further characterized regarding their antibiotic susceptibilies, abilities to form early (BioFilm Ring Test®) and mature (crystal violet staining method) biofilms and to invade osteoblasts (gentamicin protection assay). Results: The 51 included BJI were mostly chronic (88.2%), orthopedic device-related (74.5%) and polymicrobial (78.4%). After a follow-up of 60.7 weeks (IQR, 30.1-115.1), 20 (39.2%) treatment failures were observed, including 4 Corynebacterium-documented relapses, mostly associated with non-optimal surgical management (OR 7.291; p = 0.039). Internalization rate within MG63 human osteoblasts was higher for strains isolated from delayed (>3 months) BJI (p < 0.001). Infection of murine osteoblasts deleted for the β1-integrin resulted in a drastic reduction in the internalization rate. No difference was observed regarding biofilm formation. Conclusions: Surgical management plays a crucial role in outcome of BJI involving corynebacteria, as often chronic and device-associated infections. Sanctuarisation within osteoblasts, implicating the β1 cellular integrin, may represent a pivotal virulence factor associated with BJI chronicity.
Introduction: Corynebacteria represent often-neglected etiological agents of post-traumatic and/or post-operative bone and joint infection (BJI). We describe here clinical characteristics and bacteriological determinants of this condition. Methods: A retrospective cohort study described characteristics, outcome and determinants of treatment failure of all patients with proven Corynebacterium spp. BJI (i.e., ≥2 culture-positive gold-standard samples). Available strains were further characterized regarding their antibiotic susceptibilies, abilities to form early (BioFilm Ring Test®) and mature (crystal violet staining method) biofilms and to invade osteoblasts (gentamicin protection assay). Results: The 51 included BJI were mostly chronic (88.2%), orthopedic device-related (74.5%) and polymicrobial (78.4%). After a follow-up of 60.7 weeks (IQR, 30.1-115.1), 20 (39.2%) treatment failures were observed, including 4 Corynebacterium-documented relapses, mostly associated with non-optimal surgical management (OR 7.291; p = 0.039). Internalization rate within MG63 human osteoblasts was higher for strains isolated from delayed (>3 months) BJI (p < 0.001). Infection of murine osteoblasts deleted for the β1-integrin resulted in a drastic reduction in the internalization rate. No difference was observed regarding biofilm formation. Conclusions: Surgical management plays a crucial role in outcome of BJI involving corynebacteria, as often chronic and device-associated infections. Sanctuarisation within osteoblasts, implicating the β1 cellular integrin, may represent a pivotal virulence factor associated with BJI chronicity.
Authors: Véronique Roux; Michel Drancourt; Andreas Stein; Philippe Riegel; Didier Raoult; Bernard La Scola Journal: J Clin Microbiol Date: 2004-05 Impact factor: 5.948
Authors: N Benito; M Franco; A Ribera; A Soriano; D Rodriguez-Pardo; L Sorlí; G Fresco; M Fernández-Sampedro; M Dolores Del Toro; L Guío; E Sánchez-Rivas; A Bahamonde; M Riera; J Esteban; J M Baraia-Etxaburu; J Martínez-Alvarez; A Jover-Sáenz; C Dueñas; A Ramos; B Sobrino; G Euba; L Morata; C Pigrau; P Coll; I Mur; J Ariza Journal: Clin Microbiol Infect Date: 2016-05-13 Impact factor: 8.067
Authors: Stephen C Becker; Dwayne R Roach; Vinita S Chauhan; Yang Shen; Juli Foster-Frey; Anne M Powell; Gary Bauchan; Richard A Lease; Homan Mohammadi; William J Harty; Chad Simmons; Mathias Schmelcher; Mary Camp; Shengli Dong; John R Baker; Tamsin R Sheen; Kelly S Doran; David G Pritchard; Raul A Almeida; Daniel C Nelson; Ian Marriott; Jean C Lee; David M Donovan Journal: Sci Rep Date: 2016-04-28 Impact factor: 4.379
Authors: Hussam Tabaja; Don Bambino Geno Tai; Elena Beam; Matthew P Abdel; Aaron J Tande Journal: Open Forum Infect Dis Date: 2022-04-14 Impact factor: 4.423